$SATT
SATIVUS TECH CORP. Stock $satt

$satt Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000121390022047366 Filed on August 12, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$189.0K	$209.0K	$92.00K
YoY Change	-48.22%	17.42%	-84.87%
% of Gross Profit
Research & Development	$218.0K	$211.0K	$65.00K
YoY Change	74.4%	48.59%	-63.07%
% of Gross Profit
Depreciation & Amortization	$9.000K	$21.00K	$6.000K
YoY Change			-104.62%
% of Gross Profit
Operating Expenses	$218.0K	$211.0K	$157.0K
YoY Change	-55.51%	-34.06%	-79.97%
Operating Profit	-$407.0K	-$420.0K	-$157.0K
YoY Change	-16.94%	31.25%
Interest Expense	-$435.0K	-$260.0K	$578.0K
YoY Change	343.88%	-226.83%	-139.94%
% of Operating Profit
Other Income/Expense, Net	-$435.0K	-$260.0K	$578.0K
YoY Change	343.88%	-226.83%
Pretax Income	-$842.0K	-$680.0K	$421.0K
YoY Change	43.2%	491.3%	-118.87%
Income Tax
% Of Pretax Income
Net Earnings	-$842.0K	-$680.0K	$421.0K
YoY Change	58.87%	491.3%	-118.87%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.17	-$0.15	$0.11
Diluted Earnings Per Share	-$0.17	-$0.15	$106.8K
COMMON SHARES
Basic Shares Outstanding	4.194M shares	4.194M shares	4.194M shares
Diluted Shares Outstanding	4.194M shares	4.194M shares	4.194M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$191.0K	$142.0K	$353.0K
YoY Change	-79.15%	-89.27%	-80.4%
Cash & Equivalents	$191.0K	$142.0K	$353.0K
Short-Term Investments
Other Short-Term Assets	$40.00K	$107.0K	$211.0K
YoY Change	-78.95%	-35.54%	210.29%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$242.0K	$260.0K	$564.0K
YoY Change	-78.12%	-82.55%	-69.82%
LONG-TERM ASSETS
Property, Plant & Equipment	$209.0K	$214.0K	$223.0K
YoY Change	1800.0%	1845.45%	3085.71%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$243.0K	$252.0K	$223.0K
YoY Change	2109.09%	2190.91%	3085.71%
TOTAL ASSETS
Total Short-Term Assets	$242.0K	$260.0K	$564.0K
Total Long-Term Assets	$243.0K	$252.0K	$223.0K
Total Assets	$485.0K	$512.0K	$787.0K
YoY Change	-56.58%	-65.89%	-58.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$33.00K	$46.00K	$29.00K
YoY Change	0.0%	-36.99%	2800.0%
Accrued Expenses	$15.00K	$16.00K	$20.00K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$2.176M	$1.675M	$1.289M
YoY Change	15.38%	-2.73%	-18.52%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.637M	$2.983M	$2.736M
YoY Change	28.97%	24.14%	16.97%
LONG-TERM LIABILITIES
Long-Term Debt	$20.00K	$22.00K	$0.00
YoY Change		-86.5%	-100.0%
Other Long-Term Liabilities	$20.00K	$22.00K	$26.00K
YoY Change		-96.92%	-98.09%
Total Long-Term Liabilities	$20.00K	$22.00K	$26.00K
YoY Change		-97.49%	-98.24%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.637M	$2.983M	$2.736M
Total Long-Term Liabilities	$20.00K	$22.00K	$26.00K
Total Liabilities	$3.657M	$3.005M	$2.828M
YoY Change	23.59%	-13.57%	-30.46%
SHAREHOLDERS EQUITY
Retained Earnings	-$21.97M	-$21.24M
YoY Change
Common Stock	$4.000K	$4.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$3.119M	-$2.517M	-$2.041M
YoY Change
Total Liabilities & Shareholders Equity	$485.0K	$512.0K	$787.0K
YoY Change	-56.58%	-65.89%	-58.05%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$842.0K	-$680.0K	$421.0K
YoY Change	58.87%	491.3%	-118.87%
Depreciation, Depletion And Amortization	$9.000K	$21.00K	$6.000K
YoY Change			-104.62%
Cash From Operating Activities	-$239.0K	-$234.0K	-$260.0K
YoY Change	-41.42%	-38.42%	-104.73%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	-$22.00K	-$177.0K
YoY Change		450.0%	-427.78%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$9.000K
YoY Change		-147.37%
Cash From Investing Activities	$0.00	-$13.00K	-$177.0K
YoY Change		-43.48%	-427.78%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	288.0K	43.00K	-83.00K
YoY Change		-158.11%	-97.56%
NET CHANGE
Cash From Operating Activities	-239.0K	-234.0K	-260.0K
Cash From Investing Activities	0.000	-13.00K	-177.0K
Cash From Financing Activities	288.0K	43.00K	-83.00K
Net Change In Cash	49.00K	-204.0K	-520.0K
YoY Change	-112.01%	-57.23%	-124.15%
FREE CASH FLOW
Cash From Operating Activities	-$239.0K	-$234.0K	-$260.0K
Capital Expenditures	$0.00	-$22.00K	-$177.0K
Free Cash Flow	-$239.0K	-$212.0K	-$83.00K
YoY Change	-41.42%	-43.62%	-101.52%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Entity File Number EntityFileNumber	333-208814
	dei	Entity Registrant Name EntityRegistrantName	SATIVUS TECH CORP.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-2847446
	dei	Entity Address Address Line1 EntityAddressAddressLine1	#3 Bethesda Metro Center
	dei	Entity Address Address Line2 EntityAddressAddressLine2	#700
	dei	Entity Address City Or Town EntityAddressCityOrTown	Bethesda
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	06880
	dei	City Area Code CityAreaCode	800
	dei	Local Phone Number LocalPhoneNumber	608-6432
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	No
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	20000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	2983000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3358000	usd
CY2022Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	22000	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	29000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	3005000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	3387000	usd
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	4194385	shares
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	142000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	866000	usd
CY2022Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	11000	usd
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	20000	usd
CY2022Q2	us-gaap	Other Assets Current OtherAssetsCurrent	107000	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	77000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	260000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	963000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	38000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	46000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	214000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6000	usd
CY2022Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	252000	usd
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	52000	usd
CY2022Q2	us-gaap	Assets Assets	512000	usd
CY2021Q4	us-gaap	Assets Assets	1015000	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	46000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	12000	usd
CY2022Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	76000	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	110000	usd
CY2022Q2	us-gaap	Convertible Debt ConvertibleDebt	1675000	usd
CY2021Q4	us-gaap	Convertible Debt ConvertibleDebt	2994000	usd
CY2022Q2	satt	Fair Value Of Convertible Component In Convertible Loans Non Current FairValueOfConvertibleComponentInConvertibleLoansNonCurrent	1170000	usd
CY2021Q4	satt	Fair Value Of Convertible Component In Convertible Loans Non Current FairValueOfConvertibleComponentInConvertibleLoansNonCurrent	222000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	16000	usd
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4194385	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4194385	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4194385	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4194385	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	4000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	4000	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	18720000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	18595000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-21241000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-21077000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-2517000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-2478000	usd
CY2022Q2	us-gaap	Minority Interest MinorityInterest	24000	usd
CY2021Q4	us-gaap	Minority Interest MinorityInterest	106000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2493000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2372000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	512000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1015000	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	211000	usd
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	142000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	276000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	318000	usd
CY2021Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	13000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	81000	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	209000	usd
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	165000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	301000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	705000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-420000	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-320000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-577000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1104000	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-260000	usd
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	205000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	318000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1242000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-680000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-115000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-259000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2346000	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-68000	usd
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-53000	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-95000	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-87000	usd
CY2022Q2	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-612000	usd
CY2021Q2	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-62000	usd
	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-164000	usd
	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-2259000	usd
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.7
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4194385	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3257618	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4194385	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3220222	shares
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2046000	usd
CY2021Q1	satt	Stock Issued During Period Value Transactions With Noncontrolling Parties StockIssuedDuringPeriodValueTransactionsWithNoncontrollingParties	1406000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	27000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	530000	usd
CY2021Q1	satt	Issuance Of Warrants IssuanceOfWarrants	39000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	334000	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-2231000	usd
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1941000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	17000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	260000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-115000	usd
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1779000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2372000	usd
CY2022Q1	satt	Share Based Compensation To Employees And Nonemployee ShareBasedCompensationToEmployeesAndNonemployee	147000	usd
	satt	Average Exercise Price Expired AverageExercisePriceExpired	2
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants		usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	40000	usd
CY2022Q1	us-gaap	Stock Granted During Period Value Sharebased Compensation Forfeited StockGrantedDuringPeriodValueSharebasedCompensationForfeited	211000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	421000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1975000	usd
CY2022Q2	satt	Share Based Compensation To Employees And Nonemployee ShareBasedCompensationToEmployeesAndNonemployee	127000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	35000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-680000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2493000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-259000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2346000	usd
	us-gaap	Depreciation Depreciation	27000	usd
	us-gaap	Depreciation Depreciation	1000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	110000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	378000	usd
	satt	Financial Expenses Related To Loans From Related Party FinancialExpensesRelatedToLoansFromRelatedParty	-1290000	usd
	satt	Financial Expenses Related To Loans From Related Party FinancialExpensesRelatedToLoansFromRelatedParty	121000	usd
	satt	Change In Fair Value Of Convertible Component In Convertible Loan ChangeInFairValueOfConvertibleComponentInConvertibleLoan	948000	usd
	satt	Change In Fair Value Of Convertible Component In Convertible Loan ChangeInFairValueOfConvertibleComponentInConvertibleLoan	1142000	usd
	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent	-30000	usd
	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent	-140000	usd
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-34000	usd
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-22000	usd
	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	-34000	usd
	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	-96000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-494000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-918000	usd
	satt	Decrease Increase In Restricted Cash DecreaseIncreaseInRestrictedCash	-9000	usd
	satt	Decrease Increase In Restricted Cash DecreaseIncreaseInRestrictedCash	19000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	199000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	12000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-190000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-31000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	50000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	530000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-15000	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	75000	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	74000	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	1406000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-40000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1862000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-724000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	913000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	866000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	411000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	142000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1324000	usd
	us-gaap	Interest Paid Net InterestPaidNet	75000	usd
	us-gaap	Stock Issued1 StockIssued1	260000	usd
	satt	Purchase Of Fixed Assets By Issuance Of Share Capital PurchaseOfFixedAssetsByIssuanceOfShareCapital	28000	usd
CY2022Q2	satt	Retained Earning Accumulated Deficit RetainedEarningAccumulatedDeficit	21280000	usd
	satt	Operating Cash Flow OperatingCashFlow	467000	usd
CY2022Q2	us-gaap	Federal Home Loan Bank Borrowings Fair Value Disclosure FederalHomeLoanBankBorrowingsFairValueDisclosure	1170000	usd
CY2022Q2	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	1170000	usd
CY2021Q4	us-gaap	Federal Home Loan Bank Borrowings Fair Value Disclosure FederalHomeLoanBankBorrowingsFairValueDisclosure	222000	usd
CY2021Q4	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	222000	usd
	us-gaap	Debt Instrument Redemption Price Percentage DebtInstrumentRedemptionPricePercentage	0.20	pure
CY2022Q1	us-gaap	Capital Capital	500000	usd
CY2021Q4	us-gaap	Capital Capital	500000	usd
CY2022Q2	us-gaap	Fair Value Concentration Of Risk Investments FairValueConcentrationOfRiskInvestments	128000	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	18
CY2022Q2	satt	Gross Proceeds GrossProceeds	50000	usd
CY2022Q2	us-gaap	Temporary Equity Elimination As Partof Reorganization TemporaryEquityEliminationAsPartofReorganization	2000000	usd
CY2022Q2	us-gaap	Capitalization Longterm Debt And Equity CapitalizationLongtermDebtAndEquity	5000000	usd
CY2022Q2	us-gaap	Lessee Finance Lease Discount Rate LesseeFinanceLeaseDiscountRate	0.80	pure
CY2022Q2	satt	Number Of Warrant Outstanding NumberOfWarrantOutstanding	185000	shares
CY2022Q2	satt	Average Exercise Price Warrant Outstanding AverageExercisePriceWarrantOutstanding	0.43
	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	126000	usd
	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	116000	usd
	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt	18000	usd
CY2021	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt	22000	usd
CY2022Q1	satt	Exercisable Options Per Share ExercisableOptionsPerShare	1.29
CY2022Q1	satt	Exercisable Options Per Share ExercisableOptionsPerShare	4
	satt	Options Vest Description OptionsVestDescription	The options vest on a quarterly basis over a period between two and three years and expire on January 4, 2032.
	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	281000	usd
CY2022Q2	satt	Exercisable Options Per Share ExercisableOptionsPerShare	3.96
	us-gaap	Intermediate Life Plants Useful Life IntermediateLifePlantsUsefulLife	P10Y
	us-gaap	Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Volatility Rate ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate	2.23	pure
	us-gaap	Share Based Goods And Nonemployee Services Transaction Valuation Method Risk Free Interest Rate ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate	0.0171	pure
	pf0	Short Term Investments Other Average Yield ShortTermInvestmentsOtherAverageYield	0	pure
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	207000	usd
	satt	Amount Of Cancelled Share Options AmountOfCancelledShareOptions	211000	usd
	satt	Schedule Of Warrant Activity ScheduleOfWarrantActivity	<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Average<br/> exercise<br/> price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%">Warrants outstanding at January 1, 2021</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">213,083</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.81</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 9pt">Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">99,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.15</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 9pt">Exercised</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-71">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-72">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 9pt">Forfeited/Cancelled</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(66,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.15</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; padding-left: 9pt">Forfeited/Cancelled</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(47,333</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1.94</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>Warrants outstanding at December 31, 2021</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">198,750</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.54</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 9pt">Expired</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(13,750</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.00</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 9pt">Exercised</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-73">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-74">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; padding-left: 9pt">Forfeited/Cancelled</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-75">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-76">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt">Warrants outstanding at June 30, 2022</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">185,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.43</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2020Q4	satt	Number Of Warrant Outstanding NumberOfWarrantOutstanding	213083	shares
CY2020Q4	satt	Average Exercise Price Warrant Outstanding AverageExercisePriceWarrantOutstanding	0.81
CY2021	satt	Number Warrant Granted NumberWarrantGranted	99000	shares
CY2021	satt	Average Exercise Price Warrants Granted AverageExercisePriceWarrantsGranted	0.15
CY2021	satt	Numbers Warrant Forfeited Cancelled NumbersWarrantForfeitedCancelled	66000	shares
CY2021	satt	Average Exercise Prices Forfeited Cancelled AverageExercisePricesForfeitedCancelled	0.15
CY2021	satt	Number Warrant Forfeited Cancelled NumberWarrantForfeitedCancelled	47333	shares
CY2021	satt	Average Exercise Price Forfeited Cancelled AverageExercisePriceForfeitedCancelled	1.94
CY2021Q4	satt	Number Of Warrant Outstanding NumberOfWarrantOutstanding	198750	shares
CY2021Q4	satt	Average Exercise Price Warrant Outstanding AverageExercisePriceWarrantOutstanding	0.54
	satt	Number Warrant Expired NumberWarrantExpired	-13750	shares
CY2021	satt	Warrants Outstanding Shares WarrantsOutstandingShares	198750	shares
CY2021	satt	Class Of Warrant Or Righst Warrant Or Right Exercisable ClassOfWarrantOrRighstWarrantOrRightExercisable	198750	shares
	satt	Warrants Outstanding Shares WarrantsOutstandingShares	185000	shares
	satt	Class Of Warrant Or Righst Warrant Or Right Exercisable ClassOfWarrantOrRighstWarrantOrRightExercisable	185000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	166000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.1
CY2021	satt	Shares Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	120000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.01
CY2021	satt	Number Options Exercised NumberOptionsExercised	90000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.1
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	195000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.63
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	195000	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.63
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	166250	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.72
CY2022Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	195000	shares
	satt	Class Of Warrant Or Righst Warrants Or Rights Exercisable ClassOfWarrantOrRighstWarrantsOrRightsExercisable	166250	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	49025	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	227500	shares
CY2021	satt	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercised	-80525	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	196000	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	196000	shares
CY2022Q3	us-gaap	Shares Issued SharesIssued	76890	shares
CY2022Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	4.5
CY2022Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	1.36
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Stock Issued1 StockIssued1		usd
	us-gaap	Subsequent Event Description SubsequentEventDescription	During July and August 2022, Saffron Tech received a total of NIS 255 thousand in respect a crowd funding round through the Israeli crowd funding platform – Pipelbiz. Assuming the maximum amount (NIS 4.1 million) is raised, the Company will own approximately 70% of Saffron Tech.
CY2022Q2	satt	Financial Expenses Related To Interest And Revaluation FinancialExpensesRelatedToInterestAndRevaluation	250000	usd
CY2021Q2	satt	Financial Expenses Related To Interest And Revaluation FinancialExpensesRelatedToInterestAndRevaluation	-176000	usd
	satt	Financial Expenses Related To Interest And Revaluation FinancialExpensesRelatedToInterestAndRevaluation	-346000	usd
	satt	Financial Expenses Related To Interest And Revaluation FinancialExpensesRelatedToInterestAndRevaluation	1210000	usd
	satt	Expenses Due To Change In Fair Value Of Warrant ExpensesDueToChangeInFairValueOfWarrant	-39000	usd
CY2022Q2	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-10000	usd
CY2021Q2	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	29000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-28000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	7000	usd
CY2022Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-260000	usd
CY2021Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	205000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	318000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1242000	usd
	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2024-09-11
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2000	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	23000	usd
	us-gaap	Sale Of Stock Description Of Transaction SaleOfStockDescriptionOfTransaction	In the first 3 years of sales the Company shall pay 3% of the sales of the product which was developed under IIA research and development projects. In the fourth, fifth and sixth years of sales, the Company shall pay 4% of such sales and from the seventh year onwards the Company shall pay 5% of up to 100% of the amount of grants received plus interest at LIBOR.
CY2022Q3	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	100000	usd
	satt	Purchase Of Fixed Assets By Issuance Of Share Capital PurchaseOfFixedAssetsByIssuanceOfShareCapital		usd
CY2021	satt	Number Of Warrant Exercised NumberOfWarrantExercised		shares
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities		usd
CY2021	satt	Average Exercise Price Warrant Exercised AverageExercisePriceWarrantExercised
	satt	Number Of Warrant Exercised NumberOfWarrantExercised		shares
	satt	Average Exercise Price Warrant Exercised AverageExercisePriceWarrantExercised
	satt	Number Warrant Forfeited Cancelled NumberWarrantForfeitedCancelled		shares
	satt	Average Exercise Price Forfeited Cancelled AverageExercisePriceForfeitedCancelled
	satt	Shares Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
	satt	Number Options Exercised NumberOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod		shares
	satt	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod		shares
CY2022Q2	satt	Expenses Due To Change In Fair Value Of Warrant ExpensesDueToChangeInFairValueOfWarrant		usd
CY2021Q2	satt	Expenses Due To Change In Fair Value Of Warrant ExpensesDueToChangeInFairValueOfWarrant		usd
	satt	Expenses Due To Change In Fair Value Of Warrant ExpensesDueToChangeInFairValueOfWarrant		usd
CY2022Q2	us-gaap	Royalty Guarantees Commitments Amount RoyaltyGuaranteesCommitmentsAmount		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001661600

Files In Submission

Name	View Source	Status
0001213900-22-047366-index-headers.html	Edgar Link	pending
0001213900-22-047366-index.html	Edgar Link	pending
0001213900-22-047366.txt	Edgar Link	pending
0001213900-22-047366-xbrl.zip	Edgar Link	pending
f10q0622ex31-1_sativustech.htm	Edgar Link	pending
f10q0622ex31-2_sativustech.htm	Edgar Link	pending
f10q0622ex32-1_sativustech.htm	Edgar Link	pending
f10q0622ex32-2_sativustech.htm	Edgar Link	pending
f10q0622_sativustech.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
f10q0622_sativustech_htm.xml	Edgar Link	completed
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
satt-20220630.xsd	Edgar Link	pending
Show.js	Edgar Link	pending
satt-20220630_def.xml	Edgar Link	unprocessable
satt-20220630_lab.xml	Edgar Link	unprocessable
satt-20220630_pre.xml	Edgar Link	unprocessable
satt-20220630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SATT
SATIVUS TECH CORP. Stock $satt

2022 Q3 Form 10-Q Financial Statement

#000121390022047366 Filed on August 12, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SATT SATIVUS TECH CORP. Stock $satt

2022 Q3 Form 10-Q Financial Statement

#000121390022047366 Filed on August 12, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SATT
SATIVUS TECH CORP. Stock $satt